Smith Mark Alan Insider Trades

Insider Trading History

Track insider trading activity for Smith Mark Alan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director, CHIEF MEDICAL OFFICER
Holding Value $11.2k 19,915 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.96M 5,000 shares
$792.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $84k 150,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370M 300,000 shares
$1,233.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $8.35k 14,915 shares
Last Trade
Dec 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.66M 2,655 shares
$1,755.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $6.87k 12,260 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.41M 2,260 shares
$2,835.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $5.6k 10,000 shares
Last Trade
Dec 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.73M 5,000 shares
$1,746.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $84k 150,000 shares
Last Trade
Dec 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239M 150,000 shares
$1,593.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $2.8k 5,000 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 5,000 shares
$474.39
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $84k 150,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.7M 150,000 shares
$358.20
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $56k 100,000 shares
Last Trade
Oct 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127M 100,000 shares
$1,269.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $84k 150,000 shares
Last Trade
May 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108M 150,000 shares
$719.91
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $101k 180,000 shares
Last Trade
Aug 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$516M 385,000 shares
$1,341.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $0 0 shares
Last Trade
Aug 29, 2018 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$516M 385,000 shares
$1,341.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $56k 100,000 shares
Last Trade
Aug 05, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114M 100,000 shares
$1,143.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $112k 200,000 shares
Last Trade
Feb 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209M 200,000 shares
$1,044.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $56k 100,000 shares
Last Trade
Sep 19, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140M 100,000 shares
$1,404.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $70k 125,000 shares
Last Trade
Apr 26, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221M 125,000 shares
$1,764.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $44.8k 80,000 shares
Last Trade
Nov 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$274M 80,000 shares
$3,420.00
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF MEDICAL OFFICER
Holding Value $101k 180,000 shares
Last Trade
Jun 19, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$565M 180,000 shares
$3,141.00
$0.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up